tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Elevra Lithium to Issue Shares for Underwriting Fee Settlement

Story Highlights
Elevra Lithium to Issue Shares for Underwriting Fee Settlement

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Elevra Lithium ( (AU:ELV) ) just unveiled an update.

On October 24, 2025, Elevra Lithium Limited announced a proposed issue of 287,500 ordinary fully paid shares to satisfy remaining underwriting fees owed to Canaccord Genuity (Australia) Limited. This issuance, set for October 28, 2025, is part of a conditional institutional placement approved by shareholders on July 31, 2025. The shares will rank equally with existing securities, and the issuance does not require security holder approval, utilizing the company’s 15% placement capacity under ASX listing rules. This move is expected to settle outstanding financial obligations and potentially strengthen Elevra’s market position.

The most recent analyst rating on (AU:ELV) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Elevra Lithium stock, see the AU:ELV Stock Forecast page.

More about Elevra Lithium

Elevra Lithium Limited is a company operating in the lithium industry, focusing on the production and distribution of lithium products. The company is based in Brisbane, Queensland, Australia, and is listed on the Australian Securities Exchange (ASX) under the code ELV.

YTD Price Performance: 0.25%

Average Trading Volume: 731,913

Technical Sentiment Signal: Hold

Current Market Cap: A$677.2M

See more insights into ELV stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1